Abstract
Clinicians experienced in treating cancer have long been aware of the great variability in growth rates among different types of cancer and even within the same type, but until recently estimates of growth rates were largely limited to measurements of volume doubling times of solid tumors visible externally or roentgenographically (Collins et al., 1956; Collins, 1962; Garland et al., 1963; Spratt and Spratt, 1964; Charbit et al., 1971). These estimates were necessarily rough and gave little insight into the many factors which can influence the doubling time, such as the tumor cells’ intermitotic time and its variability, the relative proportions of actively proliferating and resting tumor cells, changes in the tumor’s proliferative behavior during different stages of growth, rate of cell loss, influence of vascular supply, contribution of stromal tissues, hemorrhage or necrosis to the tumor mass, and perturbations caused by therapy. Information about the comparative proliferative rates of normal tissues was also largely lacking.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexanian, R., Bergsagel, D.E., Migliore, P.J., Vaughn, W.K., Howe, C.D.: Melphalan therapy for plasma cell myeloma. Blood 31, 1–10 (1968).
Alexanian, R., Haut, A., Khan, A. U., Lane, M., McKelvey, E.M., Migliore, P. J., Stuckey, W.J., Jr., Wilson, H.E.: Treatment for multiple myeloma: combination chemotherapy with different melphalan dose regimes. J. Amer. med. Ass. 208, 1680–1685 (1969).
Austin, P.E., McCulloch, E. A., Till, J.E.: Characterization of the factor in L-cell conditioned medium capable of stimulating colony formation by mouse marrow cells in culture. J. cell Physiol. 77, 121–134 (1971).
Bagshawe, K.D.: Choriocarcinoma. The clinical biology of the trophoblast and its tumours. London: Edward Arnold Ltd. 1969.
Baikie, A.G.: What is a leukaemic remission: the evidence from cytogenetic studies. In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W.: V.C.JST. Blight, Government Printer 1972.
Baeendsen, G.W., Beoebse, J.J.: Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV X-rays. I. Effects of single exposures. Europ. J. Cancer 5, 373–391 (1969).
Barendsen, G.W., Broerse, J.J.: Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV X-rays. II. Effects of fractionated treatments, applied five times a week for several weeks. Europ. J. Cancer 6, 89–109 (1970).
Baserga, R., Rovera, G., Färber, J.: Control of cellular proliferation in human diploid fibroblasts. In Vitro 7, 80–87 (1971).
Beierle, J.W.: Cell proliferation: enhancement by extracts from cell surfaces of polyoma-virus-transformed cells. Science 161, 798–799 (1968).
Bennington, J. L.: Cellular kinetics of invasive squamous carcinoma of the human cervix. Cancer Res. 29, 1082–1088 (1969).
Bernard, J., Jacquiliat, C., Weil, M., Boiron, M., Tänzer, J.: Present results on daunorubicin. In: Recent results in cancer research. Advances in the treatment of acute (blastic) leukemias, vol. 30. Berlin-Heidelberg-New York: Springer 1970.
Bichel, P.: Autoregulation of ascites tumour growth by inhibition of the G-1 and the G-2 phase. Europ. J. Cancer 7, 349–355 (1971).
Boggs, D.R., Sofferman, S.A., Wintrobe, M.M., Cartwright, G.E.: Factors influencing the duration of survival of patients with chronic lymphocytic leukemia. Am. J. Med. 40, 243–254 (1966).
Bradley, T.R., Sumner, M.A., Fry, P.A.: Some factors influencing colony development of murine haemopoietic cells in vitro. In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W.: V.C.N. Blight, Government Printer 1972.
Brown, C.H., III, Carbone, P.P.: In vitro growth of normal and leukemic human bone marrow. J. nat. Cancer Inst. 46, 989–1000 (1971).
Bruce, W.R., Bergsagel, D.E.: On the application of results from a model system to the treatment of leukemia in man. Cancer Res. 27, 2646–2649 (1967).
Bruce, W.R., Lin, H.: An empirical cellular approach to the improvement of cancer chemo-therapy. Cancer Res. 29, 2308–2310 (1969).
Bruce, W.R., Meeker, B.E., Powers, W.E., Valeriote, F.A.: Comparison of the dose- and time-survival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin. J. nat. Cancer Inst. 42, 1015–1025 (1969).
Bruce, W.R., Meeker, B.E., Valeriote, F.A.: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J. nat. Cancer Inst. 37, 233–245 (1966).
Bruce, W.R., Valeriote, F.A.: Normal and malignant stem cells and chemotherapy. In: The proliferation and spread of neoplastic cells. Baltimore: Williams and Wilkins Co. 1968.
Buell, D.N., Fahey, J. L.: Limited periods of gene expression in immunoglobulin-synthesizing cells. Science 164, 1524–1525 (1969).
Bullough, W.S.: Mitotic and functional homeostasis: A speculative review. Cancer Res. 25, 1683–1727 (1965).
Bullough, W.S., Laurence, E.B., Iversen, O.H., Elgjo, K.: The vertebrate epidermal chalone. Nature (Lond.) 214, 578–580 (1967).
Burchenal, J.H.: Chemotherapy for leukemia and lymphoma. Postgrad. Med. 48, 164–168 (1970a).
Burchenal, J.H.: Clinical evaluation and future prospects of asparaginase. In: Recent results in cancer research. Advances in the treatment of acute (blastic) leukemias, vol. 30. Berlin-Heidelberg-New York: Springer 1970b.
Burger, M.M.: Cell surfaces in neoplastic transformation. In: Current topics in cellular regulation, vol. 3. New York-London: Academic Press 1971.
Burger, M.M., Noonan, K.D.: Restoration of normal growth by covering of agglutinin sites on tumour cell surface. Nature (Lond.) 228, 512–515 (1970).
BĂĽrk, R.R., Williams, C.A.: Attempts to isolate SV40 transformation factor. In: Growth control in cell cultures. Edinburgh-London: Livingstone 1971.
Burns, E.R.: On the failure of self-inhibition of growth in tumors. Growth 33, 25–45 (1969).
Cairnie, A.B.: Cell proliferation studies in the intestinal epithelium of the rat: response to continuous irradiation. Radiat. Res. 32, 240–264 (1967).
Cairnie, A.B., Lamerton, L.F., Steel, G.G.: Cell proliferation studies in the intestinal epithelium of the rat. Exp. cell. Res. 39, 528–538, 539–553 (1965).
Carbone, P.P., Berard, C.W., Bennett, J.M., Ziegler, J.L., Cohen, M.L., Gerber, P.: Burkitt’s tumor. Annals intern. Med. 70, 817–832 (1969).
Carbone, P.P., Ziegler, J.L., Morrow, R., Kyalwazi, S., Brown, C.H., DeVita, V.T., Berard, C.W.: Burkitt’s tumor: a comparative study in Africa and the United States. In: Recent results in cancer research. Normal and malignant cell growth, vol. 17. Berlin-Heidelberg-New York: Springer 1969.
Carey, R.W.: Comparative study of cytosine arabinoside (CA) therapy alone and combined with thioguanine (TG), mercaptopurine (MP) or daunomycin (DN) in acute myelocytic leukemia (AML). Proc. Amer. Assn. Cane. Res. 11, 15 (1970).
Chan, B.W.B., Bullimore, J.A., Hayhoe, F.G.J.: Extracorporeal irradiation of the blood in acute myeloid leukaemia: a clinical and in vitro culture study. Brit. J. Haemat. 17, 309 (1969).
Chan, B.W.B., Hayhoe, F.G.J.: Changes in proliferative activity of marrow leukemic cells during and after extracorporeal irradiation of blood. Blood 37, 657–663 (1971).
Chan, S.H., Metcalf, D., Gunz, F.W.: Serum inhibitors of colony stimulating factor in leukaemia. In: The nature of leukemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W.: V.C.N. Blight, Government Printer 1972.
Charbit, A., Malaise, E.P., Tubiana, M.: Relation between the pathological nature and the growth rate of human tumors. Europ. J. Cancer 7, 307–315 (1971).
Chervenick, P.A., Ellis, L.D., Pan, S.F., Lawson, A.L.: Human leukemic cells: in vitro growth of colonies containing the Philadelphia (Ph.) chromosome. Science 174, 1134–1135 (1971).
Choquet, C., Chavaudra, N., Malaise, E.: The influence of allogeneic inhibition and tumour age on the kinetics of L1210 leukaemia in vivo. Europ. J. Cancer 6, 373–378 (1970).
Clarke, G.D., Stoker, M.G. P., Ludlow, A., Thornton, M.: Requirement of serum for DNA synthesis in BHK 21 cells: effects of density, suspension and virus transformation. Nature (Lond.) 227, 798–801 (1970).
Clarkson, B.D.: Review of recent studies of cellular proliferation in acute leukemia. In: Human tumor cell kinetics, monograph no. 30. Bethesda: National Cancer Institute 1969.
Clarkson, B.D.: Clinical contribution of cytokinetics and cytogenetics to leukemia. Presented at Tenth International Cancer Congress, Houston, Texas (1970 a).
Clarkson, B.D.: Unpublished observations 1972 a.
Clarkson, B.D.: Acute Myelocytic Leukemia in Adults. Cancer 30, 1572–1582 (1972b).
Clarkson, B.D., Pried, J.: Changing concepts of treatment in acute leukemia. In: Medical Clinics of North America, vol. 55. Philadelphia-London-Toronto: Saunders 1971a.
Clarkson, B.D., Fried, J., Strife, A., Sakai, Y., Ota, K., Ohkita, T.: Studies of cellular proliferation in human leukemia. III. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for eight to ten days. Cancer 25, 1237–1260 (1970b).
Clarkson, B.D., Fried, J., Strife, A., Sakai, Y., Ota, K., Ohkita, T., Masuda, R.: Studies of cellular proliferation in human leukemia. IV. Behavior of normal hematopoietic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine. Cancer 26, 1–19 (1970c).
Clarkson, B.D., Krakoff, L, Burchenal, J., Karnofsky, D., Golbey, R., Oettgen, H., Dowling, M., Lipton, A.: Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Cancer 25, 279–305 (1970d).
Clarkson, B.D., Ota, K., Ohkita, T., O’Connor, A.: Kinetics of proliferation of cancer cells in neoplastic effusions in man. Cancer 18, 1189–1213 (1965).
Clarkson, B.D., Ohkitaj T., Ota, K., Fried, J.: Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine. J. clin. Invest. 46, 506–529 (1967).
Clarkson, B.D., Sakai, Y., Kimura, T., Ohkita, T., Fried, J.: Studies of cellular proliferation in human leukemia. II. Variability in rates of growth and cellular differentiation in acute myelomonoblastic leukemia and effects of treatment. In: The proliferation and spread of neoplastic cells. Baltimore: The Williams and Wilkins Company 1968.
Clarkson, B.D., Todo, A., Ogawa, M., Gee, T.S., Fried, J.: Consideration of the cell cycle in chemotherapy of acute leukemia. In: Recent results in cancer research. Current concepts in the management of lymphoma and leukemia. Berlin-Heidelberg-New York: Springer 1971b.
Coffino, P., Laskov, R., Scharff, M.D.: Immunoglobulin production: method for quantitatively detecting variant myeloma cells. Science (Washington) 167, 186–188 (1970).
Cohn, I., Jr., Slack, N.H., Fisher, B.: Complications and toxic manifestations of surgical adjuvant chemotherapy for breast cancer. Surg. Gynecol. Obstet. 127, 1201–1209 (1968).
Collins, V.P.: Time of occurrence of pulmonary metastasis from carcinoma of the colon and rectum. Cancer 15, 387–395 (1962).
Collins, V.P., Loeffler, R.K., Tivey, H.: Observations on growth rates of human tumors. Amer. J. Roentgenol. 76, 988–1000 (1956).
Cooper, E.H., Frank, G.L., Wright, D. H.: Cell proliferation in Burkitt’s lymphoma. Europ. J. Cancer 2, 377–384 (1966).
Cooper, E.H., Peckham, M.J., Millard, R.E., Hamlin, I.M.E., Gerard-Marchant, R.: Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. Europ. J. Cancer 4, 287–296 (1968).
Cooper, H.L.: Biochemical alterations accompanying initiation of growth in resting cells. In: The cell cycle and cancer. Dekker: New York 1971.
Court-Brown, W.M., Tough, I. M.: Cytogenetic studies in chronic myeloid leukemia. Advanc. Cancer Res. 7, 351–381 (1963).
Croizat, H., Frindel, E., Tubiana, M.: Proliferative activity of the stem cells in the bone marrow of mice after single and multiple irradiation (total or partial body exposure). Inter. J. Radiat. Biol. 18, 347–358 (1970).
Cronkite, E.P.: Extracorporeal irradiation of blood in the treatment of chronic lymphocytic leukemia. In: Recent results in cancer research. Current concepts in the management of leukemia and lymphoma, vol. 36. Berlin-Heidelberg-New York: Springer 1971.
Crowther, D., Hamilton Fairley, G., Sewell, R.: Significance of the changes in the circulating lymphoid cells in Hodgkin’s disease. Brit. med. J. 2, 473–477 (1969).
Crowther, D., Bateman, C.J.T., Vartan, C.P., Whitehouse, J.M.A., Malpas, J.S., Fairley, G.H., Scott, R.B.: Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukemia. Brit. med. J. 4, 513–517 (1970).
Curtis, J.E., Hersh, E.J., Freireich, E.J.: Leukapheresis therapy of chronic lymphocytic leukemia. Blood 39, 163–175 (1972).
Denekamp, J.: Cellular proliferation kinetics of animal tumours. Cancer Res. 30, 393–400 (1970).
Denekamp, J., Thomlinson, R.H.: The cell proliferation kinetics of four experimental tumors after acute x-irradiation. Cancer Res. 31, 1279–1284 (1971).
deVita, V. T.: Cell kinetics and the chemotherapy of cancer. Cancer Chemother. Rep. 2, 23–33 (1971a).
Devita, V.T.: Chemotherapy of the lymphomas. In: Recent results in cancer research. Current concepts in the management of leukemia and lymphoma, vol. 36. Berlin-Heidelberg-New York: Springer 1971b.
Devita, V.T., Serpick, A.A., Carbone, P.P.: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann. int. Med. 73, 881–895 (1970).
Djordjevic, B., Tolmach, L.J.: X-ray sensitivity of HeLa S3 cells in the G 2 phase: comparison of two methods of synchronization. Biophys. J. 7, 77–94 (1967).
Dowling, M.D., Gee, T.S., Lee,B.J., Clarkson, B.D., Burchenal, J.H.: Treatment of acute non-lymphoblastic leukemia with arabinosylcytosine (AraC) and 6-Thioguanine (TG) every 12 hours. Proc. Am. Assn. Cancer Res. 13, 21 (1972).
Dulbecco, R.: Topoinhibition and serum requirement of transformed and untransformed cells. Nature (Lond.) 227, 802–806 (1970a).
Dulbecco, R., Stoker, M.: Conditions determining initiation of DNA synthesis in 3T3 cells. Proc. nat. Acad. Sci. (Wash.) 66, 204–210 (1970b).
Dutreix, J., Tubiana, M., Wambersie, A., Malaise, E.: The influence of cell proliferation in tumours and normal tissues during fractionated radiotherapy. Europ. J. Cancer 7, 205–213 (1971).
Elkind, M.M., Sutton, H.: X-ray damage and recovery in mammalian cells in culture. Nature (Lond.) 184, 1293–1295 (1959).
Elkind, M.M., Sinclair, W.K.: Recovery in X-irradiated mammalian cells. In: Current topics in radiation research. Amsterdam: Holland 1965.
Elkind, M.M., Sakamoto, K., Kamper, C.: Age-dependent toxic properties of Actinomycin D and X-rays in cultured Chinese hamster cells. Cell Tissue Kinet. 1, 209–224 (1968).
Engeset, A., Cooper, E.H., Brennhovd, L, Hoeg, K.: The thoracic duct lymph in Hodgkin’s disease. II. Quantitative analysis of the cellular composition of the lymph. Int. J. Cancer 8, 113–121 (1971).
Epifanova, O.I: Effects of hormones on the cell cycle. In: The cell cycle and cancer. New York: Dekker 1971.
Ernst, P., Killmann, S.: Perturbation of generation cycle of human leukemic blast cells by cytostatic therapy in vivo: effect of corticosteroids. Blood 36, 689–696 (1970).
Ernst, P., Killmann, S.: Perturbation of generation cycle of human leukemic myeloblasts in vivo by methotrexate. Blood 38, 689–705 (1971).
Everson, T.C., Cole, W.H.: Spontaneous regression of cancer. Philadelphia-London: Saunders 1966.
Fahey, J.L., Buell, D.N., Sox, H.C: Proliferation and differentiation of lymphoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis. Ann. N. Y. Acad. Sci. 190, 221–234 (1971).
Fairley, G. H.: Clinical experience with L-asparaginase in Britain. In: Recent results in cancer research. Advances in the treatment of acute (blastic) leukemias, Vol. 30. Berlin-Heidelberg- New York: Springer 1970.
Farber, S.: Neuroblastoma. Am. J. Dis. Child. 60, 749 (1940).
Farber, S.: Current clinical and experimental studies in cancer chemotherapy. Cancer Chemother. Rep. 13, 159–165 (1961).
Fialkow, P.J., Bryant, J.I., Thomas, E.D., Neiman, P.E.: Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1, 251–255 (1971).
Fisher, B.: Status of adjuvant therapy: results of the national surgical adjuvant breast project studies in oophorectomy, postoperative radiation therapy and chemotherapy. Cancer 28, 1654–1658 (1971).
Fisher, B., Ravdin, R.G., Ausman, R.K., Slack, N.H., Moore, G.E., Noer, R.J.: Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann. Surg. 168, 337–356 (1968).
Fisher, B., Moore, G.E., Ravdin, R.G., Ausman, R.K., Slack, N.H., Noer, R.J.: Surgical adjuvant chemotherapy in the treatment of breast cancer. In: Breast cancer: early and late. Thirteenth Annual Clinical Conference on Cancer, 1968, The University of Texas M. D. Anderson Hospital and Tumor Institute. Chicago: Year Book Medical Publishers 1970a.
Fisher, B., Slack, N.H., Cavanaugh, P.J., Gardner, B., Ravdin, R.G.: Postoperative radiotherapy in the treatment of breast cancer: results of the NSABD clinical trial. Ann. Surg. 172, 711–732 (1970b).
Fitzgerald, P.H., Adams, A., Gunz, F.W.: Chromosome studies in adult acute leukemia. J. nat. Cancer Inst. 32, 395–417 (1964).
Folkman, J.: Tumor angiogenesis: therapeutic implications. New Eng. J. med. 285, 1182– 1186 (1971).
Fox, T.O., Pardee, A.B.: Animal cells: noncorrelation of length of G 1 phase with size after mitosis. Science 167, 80–82 (1970).
Fox, T.O., Sheppard, J.R., Burger, M.M.: Cyclic membrane changes in animal cells: transformed cells permanently display a surface architecture detected in normal cells only during mitosis. Proc. nat. Acad. Sci. 68, 224–247 (1971).
Fraumeni, J.F., Jr.: Constitutional disorders of man predisposing to leukemia and lymphoma. In: Hematopoietic neoplasms, monograph no. 32. Bethesda: National Cancer Institute 1968.
Frei, E., III., Carter, S.K.: Arabinosylcytosine: therapeutic trials in patients with neoplastic disease, unpublished.
Frei, E., III., Uio, J.H., Whang, J., Carbone, P.P.: Studies of the Philadelphia chromosome in patients with chronic myelogenous leukemia. Ann. N. Y. Acad. Sci. 113, 1073–1080 (1964).
Freibeich, E.J., Bodey, G, P., Hart, S., Eodriguez, V., Whttecar, J.P., Frei, E., III.: Kemission induction in adults with acute myelogenous leukemia. In: Recent results in cancer research. Advances in the treatment of acute (blastic) leukemias, vol. 30. Berlin-Heidelberg-New York: Springer 1970.
Frindel, E., Charruyer, F., Tubiana, M., Kaplan, H.S., Alpen, E.L.: Radiation effects on DNA synthesis and cell division in the bone-marrow of the mouse. Int. J. Radiat. Biol. 11, 435–443 (1966).
Frindel, E., Malaise, E., Alpen, E., Tubiana, M.: Kinetics of cell proliferation of an experimental tumour. Cancer Res. 27, 1122–1131 (1967).
Frindel, E., Malaise, E., Tubiana, M.: Cell proliferation kinetics in five human solid tumours. Cancer 22, 611–620 (1968).
Frindel, E., Tubiana, M.: Radiobiology and the cell cycle. In: The cell cycle and cancer. New York: Dekker 1971.
s, E., Valleron, A.J., Vassort, F., Tubiana, M.: Proliferation kinetics of an experimental ascites tumour of the mouse. Cell Tissue Kinet. 2, 51–65 (1969).
Froese, G.: Regulation of growth in Chinese hamster cells by a local inhibitor. Exp. cell Res. 65, 297–306 (1971).
Gabutti, V., Pileri, A., Tarocco, R.P., Gavosto, F., Cooper, E.H.: Proliferative potential of out-of-cycle leukaemic cells. Nature 224, 375–376 (1969).
Galbraith, P.R.: Granulocyte kinetic studies in chronic myelogenous leukemia. Nat. Cancer Inst. Monogr. 30, 121–134 (1969).
Galton, D. A.G.: Management of the chronic leukaemias. In: Recent results in cancer research. Current concep’ s in the management of leukemia and lymphoma, vol. 36. Berlin-Heidelberg- New York: Springer 1971.
Garland, L.H., Coulson, W., Wollin, E.: The rate of growth and apparent duration of untreated primary bronchial carcinoma. Cancer 16, 694–707 (1963).
Gavosto, F.: The proliferative kinetics of the acute leukaemias in relation to their treatment. Europ. J. clin. biol. Res. 15, 1042–1047 (1970).
Gavosto, F., Ptleri, A.: Cell cycle of cancer cells in man. In: The cell cycle and cancer. New York: Dekker 1971.
Gee, T.S., Dowling, M.D., Jr., Clarkson, B.D.: Combination therapy with arabinosyl-cytosine (Ara-C) and 6-thioguanine (TG) in adult patients with the acute leukemic phase of lymphosarcoma (LSA) or reticulum cell sarcoma (RCS). XIII International Congress of Hematology, Munich, 1970.
Gee, T.S., Yu, K.-P., Clarkson, B.D.: Treatment of adult acute leukemia with arabinosyl cytosine and thioguanine. Cancer 23, 1019–1032 (1969).
Gildewell, O.J., Holland, J.F.: Clinical trials of the acute leukemia Group B in acute lymphocytic leukemia (ALL). In: The 5th international symposium on comparative leukemia research, Padova-Venice, Italy, September 13–17, 1971, p. 8.
Gompertz, B.: On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Phil. Trans. 115, 513 (1825).
Goodell, R., Young, R., deVita, V.: Rapid in vivo kinetic studies in human acute leukemia (AL) by intramarrow double labelling (DL) with 3H and 14C thymidine (TdR). Proc. Amer. Assoc. Cancer Res. 11, 31 (1970).
Greenberg, P.L., Nichols, W.C., Schrier, S.L.: Granulopoiesis in acute myeloid leukemia and preleukemia. New Eng. J. Med. 284, 1225–1232 (1971).
Greene, H.S.N.: Heterologous transplantation of mammalian tumors. I. The transfer of rabbit tumors to alien species. J. exp. Med. 73, 461–479 (1941).
Griswold, D.R, Schabel, F.M., Jr., Wilcox, W.S., Simpson-Herren, L., Skipper, H.E.: Success and failure in the treatment of solid tumour. Cancer Chemother. Rep. 52, 345–387 (1968).
Griswold, D.P., Jr., Simpson-Herren, L., Schabel, F.M., Jr.: Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878). Cancer Chemother. Rep. 54, 337–346 (1970).
Haghbin, M., Tan, C., Gee, T., Dowling, M., Clarkson, B., Sidhu, J., Sykes, M., Burchenal, J., Murphy, M.L.: Sequential intensive drug therapy in acute lymphoblastic leukemia (ALL) and leukosarcoma (LSA). Proc. Am. Assn. Cancer Res. 12, 31 (1971).
Haghbin, M., Tan, C., Gee, T., Dowling, M., Clarkson, B., Sidhu, J., Sykes, M., Murphy, M.L.: Intensive chemotherapy and prophylactic intrathecal methotrexate in acute lymphoblastic leukemia (ALL). Proc. Am. Assn. Cancer Res. 13, 22 (1972).
Halpern, M., Rubin, H.: Proteins released from chick embryo fibroblasts in culture: I. Partial characterization of the proteins. Exp. cell. Res. 60, 86–95 (1970).
Hanna, I.R.A., Tarbutt, R.G., Lamerton, L.F.: Shortening of the cell-cycle time of erythroid precursors in response to anaemia. Brit. J. Haemat. 61, 381–387 (1969).
Hart, J.S., Sherakawa, S., Trujillo, J., Frei, E., III.: The mechanism of induction of complete remission in acute myeloblasts leukemia in man. Cancer Res. 29, 2300–2307 (1969).
Hart, J.S., Trujillo, J.M., Freireich, E.J., George, S.L., Frei, E., III.: Cytogenetic studies and their clinical correlates in adults with acute leukemia. Ann. intern. Med. 75, 353–360 (1971).
Henderson, E.S.: Treatment of acute leukemia. Sem. Hemat. 6, 271–319 (1969).
Henderson, E. S., Samaha, R. J.: Evidence that drugs in multiple combination have materially advanced the treatment of human malignancies. Cancer Res. 29, 2272–2280 (1969).
Hermens, A.F., Barendsen, G.W.: Cellular proliferation patterns in an experimental rhabdomyosarcoma in the rat. Europ. J. Cancer 3, 361–369 (1967).
Hermens, A.F., Barendsen, G.W.: Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after X-irradiation. Europ. J. Cancer 5, 173–189 (1969).
Hersh, E.M., Frei, E., III., Coltman, C., Luce, J.: Improved combination chemotherapy (MOPP) for remission induction and maintenance in advanced Hodgkin’s disease. Amer. Soc. Clin. Oncol., Eighth Annual Scientific Meeting Program, Boston, Mass., May 3, 1972, abstract No. 28.
Hill, J.M., Roberts, J., Loeb, E., Kahn, A., MacLellan, A., Hill, R.W.: L-Asparaginase therapy for leukemia and other malignant neoplasms. J. Amer. med. Assn. 202, 882–888 (1967).
Hobbs, J.R.: Modes of escape from therapeutic control in myelomatosis. Brit. med. J. 2, 325 (1971).
Hofer, K.G., Hofer, M.: Kinetics of proliferation, migration, and death of L1210 ascites cells. Cancer Res. 31, 402–408 (1971).
Holland, J.F., Glide well, O.: Complementary chemotherapy in acute leukemia. In: Recent results in cancer research. Advances in the treatment of acute (blastic) leukemias, vol. 30. Berlin-Heidelberg-New York: Springer 1970.
Holland, J.F., Glidewell, O.J.: Progress in chemotherapy of acute leukaemia. In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W., V.C.N. Blight, Government Printer 1972.
Holley, R.W., Kiernan, J.A.: Studies of serum factors required by 3T3 and SV3T3 cells. In: Growth control in cell cultures. Edinburgh-London: Livingstone 1971.
Holmberg, B.: A blockage in the S-phase of HeLa cells produced by a human tumor polypeptide. Europ. J. Cancer 4, 475–480 (1968).
Hoogstraten, B., Costa, J., Cuttner, J., Forcier, R. J., Leone, L.A., Harley, J.B., Glide-well, O.J.: Intermittent melphalan therapy in multiple myeloma. J. Amer. med. Ass. 209, 251–253 (1969).
Howes, A.E.: An estimation of changes in the proportions and absolute numbers of hypoxic cells after irradiation of transplanted C3H mouse mammary tumors. Brit. J. Radiol. 42, 441–447 (1969).
Huguley, C.M., Jr.: Chronic myelocytic and chronic lymphocytic leukemia. Cancer 30, 1583–1587 (1972).
Ichukawa, Y.: Differentiation of a cell line of myeloid leukemia. In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W.: V.C.N. Blight, Government Printer 1972.
Israel, L., Chahinian, P.: Evaluation of the survival gain in 22 measurable lung tumors treated with chemotherapy. An approach towards quantitative evaluation of cancer treatments in man. Europ. J. Cancer 5, 631–637 (1969).
Iverson, U., Iversen, O.H., Blumtng, A.Z., Ziegler, J.L., Kyalwasi, S.: Cell kinetics of African cases of Burkitt, lymphoma: a preliminary report. Europ. J. Cancer, 1972 in press.
Jainchtll, J., Todaro, G.J.: Stimulation of cell growth in vitro by serum with and without growth factor. Relation to contact inhibition and viral transformation. Exp. cell Res. 59, 137–146 (1970).
Jensen, M.K.: Chromosome studies in acute leukemia. III. Chromosome constitution of bone marrow cells in 30 cases. Acta med. Scand. 182, 629–644 (1967).
Johnson, R.E.: The curative radiotherapy of lymphomas. In: Recent results in cancer research. Current concepts in the management of leukemia and lymphoma, vol. 36. Berlin-Heidelberg-New York: Springer 1971.
Jones, B., Holland, J.F., Morrison, A.R., Lee, S.L., Sinks, L.F., Cuttner, J., Rausen, A., Kung, F., Pluss, H.J., Haurani, F.L, Patterson, R.B., Blom, J., Burgert, E.O., Jr., Moon, J.H., Chevalier, L., Sawitsky, A., Albala, M.M., Forcier, R.J., Falkson, G., Gildewell, O. J.: Daunorubicin (NSC-82151) in the treatment of advanced childhood lymphoblastic leukemia. Cancer Res. 31, 84–90 (1971).
Kaplan, H.S.: Radiation therapy with curative intent in the malignant lymphomas. In: Recent results in cancer research. Current concepts in the management of leukemia and lymphoma, vol. 36. Berlin-Heidelberg-New York: Springer 1971.
Keiser, G., Wagner, H.P., Frey-Wettstein, M.: Cytokinetic studies in two acute lympho-blastic leukemias. Helv. med. Acta. 34, 155–169 (1968).
Killander, D.: Intercellular variations in generation time and amounts of DNA, RNA and mass in a mouse leukemia population in vitro. Exp. cell Res. 40, 21–31 (1965).
Killander, D.: Intercellular variation in the amounts of DNA, RNA and mass in a leukemia and a fibroblast cell population in vitro. Europ. J. Cancer 3, 309–314 (1967).
Killmann, S.: Acute leukemia: the kinetics of leukemic blast cells in man. Ser. Haemat. 1, 38–102 (1968).
Killmann, S.: A biased view on the relapse and remission phase of acute myeloid leukaemia. In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W.: V.C.N. Blight, Government Printer 1972.
Kim, J.H., Evans, T.C.: Effects of X-irradiation on the mitotic cycle of Ehrlich ascites tumor cells. Radiat. Res. 21, 129–143 (1964).
Kiossoglou, K.A., Mrrus, W. J., Dameshek, W.: Chromosomal aberrations in acute leukemia. Blood 26, 610–641 (1965).
Koop, C.E., Kiesewetter, W.B., Horn, R.C: Neuroblastoma in childhood. Surgery 38, 272–278 (1955).
Kubitschek, H.E., Bendigkeit, H.E., Loken, M.R.: Onset of DNA synthesis during the cell cycle in chemostat cultures. Proc. nat. Acad. Sci. (Wash.) 57, 1611–1617 (1967).
Laird, A.K.: Dynamics of tumour growth: comparison of growth rates and extrapolation of growth curve to one cell. Brit. J. Cancer 19, 278–291 (1965).
Lajtha, L. G.: Leukemic stem cell kinetics in experimental animals. The Vth International symposium on comparative leukemia Research, Padova-Venice, Italy, September 13–17, 1971.
Lajtha, L.G., Pozzi, L.V., Schofield, R., Fox, M.: Kinetic properties of haemopoietic stem cells. Cell Tissue Kinet. 2, 39–49 (1969).
Lala, P.K.: Age-specific changes in the proliferation of Ehrlich ascites tumor cells grown as solid tumors. Cancer Res. 32, 628–636 (1972).
Lala, P.K., Maloney, M.A., Patt, H.M.: Measurement of DNA-synthesis time in myeloid-erythroid precursors. Exp. cell Res. 38, 626–634 (1965).
Lala, P.K., Patt, H.M.: Cytokinetic analysis of tumor growth. Proc. nat. Acad. Sci. (Wash.) 56, 1735–1742 (1966).
Lamerton, L.F., Steel, G. G.: Cell population kinetics in normal and malignant tissues. Progr. biophys. molec. Biol. 18, 247–283 (1968).
Lampkin, B.C., McWilliams, N.B., Matter, A.M.: The advantage of cell synchronization in therapy of myeloid leukemias in children. In: Program – American society of hematology, p. 44. Fourteenth annual meeting, San Francisco, California, December 5–7, 1971a.
Lampkin, B.C., Nagao, T., Mauer, A.M.: Drug effect in acute leukemia. J. clin. Invest. 48, 1124–1130 (1969).
Lampkin, B.C., Nagao, T., Mauer, A.M.: Synchronization and recruitment in acute leukemia. J. clin. Invest. 50, 2204–2214 (1971b).
Landau, T., Sachs, L.: Characterization of the inducer required for the development of macrophage and granulocyte colonies. Proc. nat. Acad. Sci. (Wash.) 68, 2540–2544 (1971).
Landau, T., Sachs, L.: Activation of a differentiation-inducing protein by adenine and adenine containing nucleotides. FEBS Let. 17, 339–341 (1971b).
Lee, B.J., Pinsky, C., Miller, D.G.: The management of plasma cell neoplasms. In: The medical clinics of North America, vol. 55. Philadelphia-London-Toronto: Saunders 1971.
Lesheb, S.: Compensatory reactions in intestinal crypt cells after 300 roentgens of cobalt-60 gamma irradiation. Radiat. Res. 32, 510–519 (1967).
Li, M.C., Hertz, R., Spencer, D.B.: Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc. Soc. exp. Biol. 93, 361–366 (1956).
Lipkin, M.: The proliferative cycle of mammalian cells. In: The cell cycle and cancer. New York: Dekker 1971.
Lipton, A., Klinger, L, Paul, D., Holley, R.W.: Migration of mouse 3T3 fibroblasts in response to a serum factor. Proc. nat. Acad. Sci. (Wash.) 68, 2799–2801 (1971).
Lowenbraun, S., deVita, V.T., Serpick, A.A.: Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in lymphosarcoma and reticulum cell sarcoma. Cancer 25, 1018–1025 (1970).
MacMahon, B., Levy, M.A.: Prenatal origin of childhood leukemia. Evidence from twins. New Eng. J. Med. 270, 1082–1085 (1964).
Malaise, E., Tubiana, M.: Etude in vitro de certains facteurs susceptibles d’influencer la croissance d’une ascite expérimentale. Comptes-Rendus de l’Académie de Sciences 270D, 539–542 (1970).
Mathé, G., Amiel, J.L., Clarysse, A., Hayat, M., Schwarzenberg, L.: The place of the L-asparaginase in the treatment of acute leukemias. In: Recent results in cancer research. Advances in the treatment of acute (blastic) leukemias, vol. 30. Berlin-Heidelberg-New York: Springer 1970a.
Mathé, G., Amiel, J.L., Schwarzenberg, L., Schneider, M., Cattan, A., Hayat,M., de Vassal, F., Schlumberger, J.R.: Methods and strategy for the treatment of acute lymphoblastic leukemia. In: Recent results in cancer research. Advances in the treatment of acute (blastic) leukemias, vol. 30. Berlin-Heidelberg-New York: Springer 1970b.
Mauer,A.M., Fisher, V.: Characteristics of cell proliferation in four patients with untreated acute leukemia. Blood 28, 428–445 (1966).
Mauer, A.M., Lampkin, B.C., Nagao, T.: Prospects for new directions in therapy of acute lymphoblastic leukemia. In: Hemopoietic cellular proliferation. New York: Grune & Stratton 1970.
Maurice, P.A., Alberto, P., Ferrier, S., Freund, M.: Leucémie myélocytaire chronique: «guerison» apparente depuis plus de 9 ans, consécutive à une hypoplasie médullaire thérapeutique. Schweiz. Med. Wschr. 101, 1781–1782 (1971).
Mauro, F., Madoc-Jones, H.: Age responses of cultured mammalian cells to cytotoxic drugs. Cancer Res. 30, 1397–1408 (1970).
McCulloch, E.A., Till, J.E.: Leukemia considered as defective differentiation: complementary in vivo and culture methods applied to the clinical problem. In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W.: V.C.N. Blight. Government Printer 1972.
Metcalf, D.: Inhibition of bone marrow colony formation in vitro by dialysable products of normal and neoplastic haemopoietic cells. Aust. J. exp. biol. med. Sci. 49, 351–363 (1971a).
Metcalf, D.: The nature of leukaemia: neoplasm or disorder of haemopoietic regulation? Med. J. Aust. 2, 739–746 (1971b).
Metcalf, D., Chan, S.H., Gunz, F.W., Vincent,P., Ravich, R.B.M.: Colony-stimulating factor and inhibitor levels in acute granulocytic leukemia. Blood 88, 143–152 (1971c).
Metcalf, D., Chan, S.H., Stanley, E.R., Moore, M.A.S., Gunz, F.W., Vincent, P.C: Regulation of normal and leukaemic granulocytic cells by colony stimulating factor (CSF). In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Australia: Sydney, N.S.W.: V.C.N. Blight, Government Printer, 1972.
Miller, R.W.: Deaths from childhood cancer in sibs. New Eng. J. Med. 279, 122–126 (1968).
Moore, M.A.S., Williams, N., Metcalf, D.: Characterisation of in vitro colony forming cells in acute and chronic myeloid leukaemia. In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W.: V.C.N. Blight, Government Printer 1972.
Mueller, G.C.: Biochemical perspectives of the G 1 and S intervals in the replication cycle of animal cells: a study in the control of cell growth. In: The cell cycle and cancer, vol. 1. New York: Dekker 1971.
Nias, A.H. W., Fox, M.: Synchronization of mammalian cells with respect to the mitotic cycle. Cell Tissue Kinet. 4, 375–398 (1971).
Nitze, H.R., Vosteen, K., Ganzer, U.: Radiation treatment of human tumours following the in vivo synchronization of the cell cycle. Acta Otolaryng. 71, 227–231 (1971).
Nowell, P.C., Hungerford, D.A.: Chromosome studies in human leukemia. II. Chronic granulocytic leukemia. J. nat. Cancer Inst. 27, 1013–1021 (1961).
Oettgen, H.F., Old, L.J., Boyse, E.A.: Human tumor immunology. In: The medical clinics of North America, vol. 55. Philadelphia-London-Toronto: Saunders 1971.
Oettgen, H.F., Old, L.J., Boyse, E.A., Campbell, H.A., Philips, F.S., Clarkson, B.D., Tallal, L., Leeper, R.D., Schwartz, M.K., Kim, J.H.: Inhibition of leukemias in man by L-asparaginase. Cancer Res. 27, 2619–2631 (1967).
Oettgen, H.F., Stephenson, P.A., Schwartz, M.K., Leeper, R.D., Tallal, L., Clarkson, B.D., Golbey, R.B., Krakoff, I.H., Karnofsky, D.A., Bxjrchenal, J.H.: The toxicity of E. coli L-asparaginase in man. Cancer 25, 253–278 (1970).
Ogawa, M., Bergsagel, D.E., McCulloch, E. A.: Differential effects of melphalan on mouse myeloma (adj. PC-5) and hemopoietic stem cells. Cancer Res. 31, 2116–2119 (1971).
Ogawa, M., Fried, J., Sakai, Y., Strife, A., Clarkson, B.D.: Studies of cellular proliferation in human leukemia. VI. The proliferative activity, generation time, and emergence time of neutrophilic granulocytes in chronic granulocytic leukemia. Cancer 25, 1031–1049 (1970).
Ohara, K., Fried, J., Dowling, M.D., Bittar, E.S., Clarkson, B.D.: Studies of cellular proliferation in human leukemia. VII. Cytokinetic behavior of neoplastic cells in a patient with reticulum cell sarcoma in a leukemia phase. Cancer 28, 862–885 (1971).
Paran, M., Ichtkawa, Y., Sachs, L.: Feedback inhibition of the development of macrophage and granulocyte colonies. II. Inhibition by granulocytes. Proc. nat. Acad. Sci. (Wash.) 62, 81–87 (1969).
Paran, M., Sachs, L., Barak, Y., Resnitzky, P.: In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc. nat. Acad. Sci. (Wash.) 67, 1542–1549 (1970).
Pardee, A.B.: The surface membrane as a regulator of animal cell division. In Vitro 7, 95–104 (1971).
Paul, D., Lipton, A., Klinger J.: Serum factor requirements of normal and Simian virus 40-transformed 3T3 mouse fibroblasts. Proc. nat. Acad. Sci. (Wash.) 68, 645–648 (1971).
Peckham, M.J., Cooper, E.H.: The pattern of cell growth in reticulum cell sarcoma and lymphosarcoma. Europ. J. Cancer 6, 453–463 (1970).
Peckham, M.J., Cooper, E.H.: Proliferation characteristics of the various classes of cells in Hodgkin’s disease. Cancer 24, 135–146 (1969).
Pinkel, D.: Five-year follow up of “total therapy” of childhood lymphocytic leukemia. J. Amer. Med. Ass. 216, 648–652 (1971).
Ravdin, R.G., Lewison, E.F., Slack, N.H., Dao, T.L., Gardner, B., State, D., Fisher, B.: Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma. Surg. Gynecol. Obstet. 131, 1055–1064 (1970).
Reese, A.B., Hyman, G.A., Tapley, N.Du V., Forrest, A. W.: The treatment of retinoblastoma by x-ray and triethylene melamine. Arch. Ophthal. 60, 897–906 (1958).
Reich, L., Clarkson, B.: Unpublished observations 1972.
Reich, L., Ohara, K., Stoerzinger, P., Clarkson, B.: Effect of massive leukapheresis on proliferation in acute myeloblastic leukemia (AML). Proc. Amer. Assn. Cancer Res. 12, 25 (1971).
Robinson, W.A., Entringer, M.A., Otsuka, A.L.: In vitro studies in acute granulocytic leukaemia in humans. In: The nature of leukaemia. Proceedings of the International Cancer Conference, Sydney, 1972. Sydney, N.S.W.: C.V.N. Blight, Government Printer 1972.
Robinson, W.A., Pike, B.L.: Leukopoietic activity in human urine. New Eng. J. Med. 282, 1291–1297 (1970).
Rosen, P.J., Perry, S., Schabel, F.M., Jr.: Proliferative capacity of leukemic cells in AKR leukemia. J. nat. Cancer Inst. 45, 1169–1178 (1970).
Rubin, H.: A substance in conditioned medium which enhances the growth of small numbers of chick embryo cells in vitro. Exp. cell Res. 41, 138–148 (1966).
Rytomaa, T.: Granulocytic chalone and antichalone. In: In vitro, Vol.4. Philadelphia: Williams and Wilkins 1969.
Sachs, L.: Feedback control of the development of hematopoietic cell clones in vitro and the mechanism of leukemogenesis. In: Canadian cancer conference 8. Canada: Pergamon 1968.
Salmon, S.E.: Immunoglobulin synthesis and tumor cell number and the natural history of multiple myeloma. Brit. med. J. 2, 321 (1971a).
Salmon, S.E., McIntyre, C.R., Ogawa, M.: IgE Myeloma: total body tumor cell number and synthesis of IgE and DNA. Blood 37, 696–705 (1971b).
Salmon, S.E., Smith, B.A.: Sandwich solid phase radioimmunoassays for the characterization of human immunoglobulins synthesized in vitro. J. Immunol. 104, 665–672 (1970a).
Salmon, S.E., Smith, B.A.: Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J. clin. Invest. 49, 1114–1121 (1970b).
Salmon, S.E., Smith, B.A.: Induction of tumor-susceptibility to cycle-active agents in IgG multiple myeloma. Clin. Res. 20, 570 (1972).
Sandberg, A. A.: The chromosomes and causation of human cancer and leukemia. Cancer Ees. 26, 2064–2081 (1966).
Saunders, E.F.: Maturation of hemolysin-producing cell clones. I. The kinetics of the induction period of an in vitro hemolysin response to erythrocyte antigen. J. exp. Med. 130, 543–556 (1969).
Saunders, E.F., Lampkin, B.C., Mauer, A.M.: Variation of proliferative activity in leukemic cell populations of patients with acute leukemia. J. clin. Invest. 46, 1356–1363 (1967).
Saunders, E.F., Mauer, A.M.: Reentry of nondividing leukemic cells into a proliferative phase in acute childhood leukemia. J. clin. Invest. 48, 1299–1305 (1969).
Schabel, F.M., Jr.: In vivo leukemic cell kill kinetics and “curability” in experimental systems. In: The proliferation and spread of neoplastic cells. Baltimore: Williams and Wilkins 1968.
Schabel, F.M., Jr.: The use of tumor growth kinetics in planning “curative” chemotherapy of advanced solid tumors. Cancer Res. 29, 2384–2389 (1969).
Schabel, F.M., Jr., Skipper, H.E., Trader, M.W., Laster, W.R., Simpson-Herren, L.: Spontaneous AK leukemia (lymphoma) as a model system. Cancer Chemother. Rep. 53, 329–344 (1969).
Scher, C.D., Nelson-Rees, W.A.: Direct isolation and characterization of “flat” SV 40-transformed cells. Nature (Lond.) 233, 263–265 (1971).
Scher, C.D., Todaro, G.J.: Selective growth of human neoplastic cells in medium lacking serum growth factor. Exp. cell Res. 68, 479–481 (1971).
Schiffer, L.M.: Kinetics of chronic lymphocytic leukemia. Ser. Haemat. 1, 3–23 (1968).
Shanklin, D.R., Sotelo-Avila, C.: In situ tumors in fetuses, newborns and young infants. Biol. Neonat. 14, 286–316 (1969).
Sheehy, P.F., Fried, J., Winn, R., Clarkson, B.D.: Cell cycle changes in ovarian cancer after arabinosylcytosine (Ara-C). Proc. Amer. Assn. Cancer Res. 13, 71 (1972).
Shipley, W.U.: Immune cytolysis in relation to the growth cycle of Chinese hamster cells. Cancer Res. 31, 925–929 (1971).
Shirakawa, S., Luce, J.K., Tannock, I.F., Frie, E., III: Cell proliferation in human melanoma. J. clin. Invest. 49, 1188–1199 (1970).
Simone, J., Pinkel,D.: Rationale and results of combination chemotherapy and cranial irradiation in acute lymphocytic leukemia. In: The 5th international symposium on comparative leukemia research, Padova-Venice, Italy, September 13–17, 1971.
Simpson-Herren, L., Lloyd, H.H.: Kinetic parameters and growth curves for experimental tumor systems. Cancer Chemother. Rep. 54, 143–174 (1970).
Sinclair, W.K.: Cyclic x-ray responses in mammalian cells in vitro. Radiat. Res. 33, 620–643 (1968).
Skipper, H.E.: Cellular kinetics associated with “curability” of experimental leukemias. In: Perspectives in leukemia. New York: Grune and Stratton 1968.
Skipper, H.E.: The cell cycle and chemotherapy of cancer. In: The cell cycle and cancer. New York: Dekker 1971a.
Skipper, H.E.: Kinetic behaviour versus response to chemotherapy. J. Nat. Cancer Inst., in press.
Skipper, H.E., Schabel, F.M., Jr., Trader, M.W., Laster, W.R., Jr.: Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia. Cancer Chemother. Rep. 53, 345–366 (1969).
Smith, H.S., Gelb, L.D., Martin, M.A.: Detection and quantitation of simian virus 40 genetic material in abortively transformed BALB/3T3 clones. Proc. nat. Acad. Sci. (Wash.) 69, 152–156 (1972).
Smith, H.S., Scher, C.D., Todaro, G.J.: Induction of cell division in medium lacking serum growth factor by SV40. Virology 44, 359–370 (1971).
Spratt, J.S., Jr., Spratt, T.L.: Rates of growth of pulmonary metastases and host survival. Ann. Surg. 159, 161–171 (1964).
Stackpole, C.W., Aoki, T., Boyse, E.A., Old, L.J., Lumley-Frank, J., deHarven, E.: Cell surface antigens: serial sectioning of single cells as an approach to topographical analysis. Science 172, 472–474 (1971).
Stanley, E.R., Metcalf, D.: Partial purification and some properties of the factor in normal and leukaemic human urine stimulating mouse bone marrow colony growth in vitro. Aust. J. exp. biol. med. Sci. 47, 467–483 (1969).
Steel, G.G.: Cell loss as a factor in the growth rate of human tumours. Brit. J. Cancer 3, 381–387 (1967).
Steel, G.G.: The cell cycle in tumours: an examination of data gained by the technique of labelled mitoses. Cell Tissue Kinet. 5, 87–100 (1972).
Steel, G.G., Lamerton, L.F.: The growth rate of human tumours. Brit. J. Cancer 20, 74–86 (1966).
Stoker, M.G.P., Clarke, G. D., Thornton, M.: Density dependent stimulation of thymidine incorporation in BHK 21 cells by active material released from the same cells. J. cell. Physiol. 78, 345–354 (1971).
Stryckmans, P.A., Cronkite, E.P., Fache, J., Fliedner, T.M., Ramos, J.: DNA synthesis time of erythropoietic and granulopoietic cells in human beings. Nature (Lond.) 211, 717–720 (1966).
Stryckmans, P.A., Delalieux, G., Manaster, J., Socquet, M.: The potentiality of out-of-cycle acute leukemic cells to synthesize DNA. Blood 36, 697–703 (1970).
Stryckmans, P.A., Manaster, J., Socquet, M.: The effect of daunomycin on proliferation and survival of human leukemic blasts in vivo. In: Recent results in cancer research. Advances in the treatment of acute (blastic) leukemias, vol. 30. Berlin-Heidelberg-New York: Springer 1970.
Suit, H., Urano, M.: Repair of sublethal radiation injury in hypoxic cells of a C3H mouse mammary carcinoma. Radiat. Res. 37, 423–434 (1969).
Sullivan, P. W., Salmon, S.E.: Kinetics of tumor growth and regression in IgG multiple myeloma. J. clin. Invest., in press.
Takahashi, M., Old, L.J., McIntire, K.R., Boyse, E.A.: Immunoglobulin and other surface antigens of cells of the immune system. J. exp. Med. 134, 815–832 (1971).
Takahashi, M., Yagi, Y., Moore, G.E., Pressman, D.: Immunoglobulin production in synchronized cultures of human hematopoietic cell lines. I. Variation of cellular immuno-globulin level with generation cycle. J. Immunol. 103, 834–843 (1969).
Tallal, L., Tan, C., Oettgen, H., Wollner, N., McCarthy, M., Helson, L., Burchenal, J., Karnofsky, D., Murphy, M.L.: E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer 25, 306–320 (1970).
Tan, C., Tasaka, H., Yu, K.P., Murphy, L., Karnofsky, D.A.: Daunomycin, an antitumor antibiotic in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer 20, 333–353 (1967)
Tannock, I.F.: The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Brit. J. Cancer 22, 258–273 (1968).
Tannock, I.F.: A comparison of cell proliferation parameters in solid and ascites Ehrlich tumours. Cancer Res. 29, 1527–1534 (1969).
Tannock, I.F.: Population kinetics of carcinoma cells, capillary endothelial cells, and fibro-blasts in a transplanted mouse mammary tumor. Cancer Res. 30, 2470–2476 (1970).
Tarbutt, R.G.: Cell population kinetics of the erythroid system in the rat. The response to protracted anaemia and to continuous X-irradiation. Brit. J. Haemat. 16, 9–24 (1969).
Temin, H.M.: Stimulation by serum of multiplication of stationary chicken cells. J. cell Physiol. 78, 161–170 (1971).
Terasima, T., Tolmach, L.J.: Changes in x-ray sensitivity of Hela cells during the division cycle. Nature (Lond.) 190, 1210–1211 (1961).
Terz, J.J., Curutchet, P., Lawrence, W., Jr.: Analysis of the cell kinetics of human solid tumors. Cancer 28, 1100–1110 (1971).
Thomlinson, R.H.: Change in oxygenation in tumors in relation to irradiation. In: Frontiers of radiation therapy and oncology, vol. 3. Basel: S. Karger 1968.
Thomlinson, R.H., Craddock, E.A.: The gross response of an experimental tumor to single doses of x-rays. Brit. J. Cancer 21, 108–123 (1967).
Till, J.E., McCulloch, E.A.: Initial stages of cellular differentiation in the blood-forming system of the mouse. In: Developmental aspects of cell cycle. New York: Academic Press 1971.
Tobey, R.A., Petersen, D.F., Anderson, E.C.: Biochemistry of G 2 and mitosis. In: The cell cycle and cancer. New York: Dekker 1971.
Todaro, G.J., Lazar, G.K., Green, H.: The initiation of cell division in a contact-inhibited mammalian cell line. J. Cell Comp. Physiol. 66, 325–333 (1965).
Todo, A.: Proliferation and differentiation of hematopoietic cells in hematology disorders. III. In vivo radioautographic study of leukemia including erythro-leukemia. Acta. Haemat. Jap. 31, 947–966 (1968).
Trentin, J.J.: Influence of hematopoietic organ stroma (hematopoietic inductive micro-environments) on stem cell differentiation. In: Regulation of hematopoiesis. New York: Appleton-Century-Crofts 1970.
Tubiana, M.: Review article. The kinetics of tumor cell proliferation and radiotherapy. Brit. J. Radiol. 44, 325–347 (1971).
Tubiana, M., Frindel, E., Malaise, E.: The application of radiobiologic knowledge and cellular kinetics to radiation therapy. Am. J. Roentgenol. 102, 822–829 (1968).
Van Peperzeel, H.A.: Patterns of tumour growth after irradiation. Groningen: Drukkerju van Denderen 1970.
Venditti, J.M.: Treatment schedule dependency of experimentally active antileukemic (L1210) drugs. Cancer Chemother. Rep. 2, 35–59 (1971).
Vietti, T. J., Stabling, K., Wilbur, J.R., Lonsdale, D., Lane, D.M.: Vincristine, prednisone and daunomycin in acute leukemia of childhood. Cancer 27, 602–607 (1971).
Wagner, H.P., Cottier, H., Cronkite, E.P.: Variability of proliferative patterns in acute lymphoid leukemia of children. Blood 39, 176–186 (1972).
Whang-Peng, J., Perey, S., Knutsen, T.A., Gabt, J. J.: Cell cycle characteristics, maturation, and phagocytosis in vitro of blast cells from patients with chronic myelocytic leukemia. Blood 38, 153–161 (1971).
Whitmoee, W., Ray, B., Mount, B.: Experience with retroperitoneal lymph node dissection and adjuvant chemotherapy in germinal testis tumors, in press.
Wiebel, F., Basebga, R.: Cell proliferation in newly transplanted Ehrlich ascites tumor cells. Cell Tissue Kinet. 1, 273–289 (1968).
Yatvin, M.B., Ceouse, D.T., Clifton, K.H.: Studies on the mechanism of the stimulatory effect of lethally irradiated cells on tumour inocula. Proc. Soc. exp. Biol. (N. Y.) 133, 1123–1128 (1970).
Yeh, J., Fisheb, H.W.: A diffusible factor which sustains contact inhibition of replication. J. cell Biol. 40, 382–388 (1969).
Young, J.M., Fowler, J.F.: The effect of x-ray induced synchrony on two-dose cell survival experiments. Cell Tissue Kinet. 2, 95–111 (1969).
Young, R.C., de Vita, V.T.: Cell cycle characteristics of human solid tumours in vivo. Cell Tissue Kinet. 3, 285–290 (1970).
Ziegler, J.L., Morrow, R.H., Jr., Fass, L., Kyalwazi, S.W., Carbone, P.P.: Treatment of Burkitt’s tumor with cyclophosphamide. Cancer 26, 474–484 (1970).
Zuelzer, W.W., Cox, D.E.: Genetic aspects of leukemia. Seminars in Hemat. 6, 228–249 (1969).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Clarkson, B. (1974). Clinical Applications of Cell Cycle Kinetics. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive